INOVIO Completes BLA Submission for INO-3107, a DNA Immunotherapy for Recurrent Respiratory Papillomatosis

Recurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need INO-3107 previously rece...

November 04, 2025 | Tuesday | News
Virax Biolabs Completes Full UK Recruitment for ViraxImmune™ Clinical Study on Long COVID and Related Syndromes

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses t...

November 04, 2025 | Tuesday | News
NeuroKaire and Compass Pathways Partner to Advance AI-Driven Insights Into Psychedelic Therapies for Mental Health

Collaboration will leverage AI-powered neural analysis and Compass' expertise in psychedelic drug development to advance new therapies for mental health ...

November 03, 2025 | Monday | News
Bio Usawa Biotechnology Expands to Europe With Launch of Frankfurt-Based Subsidiary

Bio Usawa Biotechnology Ltd (Rwanda) proudly announces the establishment of its new European subsidiary, Bio Usawa Biotech Europe GmbH, headquartered in ...

November 03, 2025 | Monday | News
Biocare Medical and Hamamatsu Announce Strategic Collaboration to Advance Innovation in Spatial Biology

Biocare Medical, a global leader in immunohistochemistry instrumentation, antibodies and reagents, and Hamamatsu Corporation, a worldwide innovator in im...

October 31, 2025 | Friday | News
Pillar Biosciences and Hamilton Debut Automated Workflow for Rapid MPN NGS Testing on Microlab STAR

Pillar Biosciences, Inc., and Hamilton Company  announced the validation and release of their first automated NGS library preparation method under t...

October 31, 2025 | Friday | News
Thermo Fisher Scientific to Acquire Clario for $8.9 Billion to Accelerate Digital Transformation of Clinical Research

Expected to be immediately accretive to Adjusted Earnings Per Share (EPS)¹ after close Attractive return profile given high growth and strong margi...

October 30, 2025 | Thursday | News
IN8bio Adds The Ohio State University as New Clinical Site for INB-100 Phase 1 Trial

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune dise...

October 30, 2025 | Thursday | News
Avance Clinical Launches CNS Center of Excellence to Advance Global Biotech Trials

Avance Clinical, the award-winning Australian led, global CRO built exclusively to service the clinical research needs of biotech companies, announced th...

October 29, 2025 | Wednesday | News
Gelteq Initiates Preclinical Trial with Monash University to Advance Oral Delivery of Oily and Poorly Soluble Drugs

Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solution...

October 24, 2025 | Friday | News
Abzena Grants Orion Exclusive License to CHAb™-Designed Antibody Targeting High-Unmet-Need Cancer

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced that Orion has obtained an exclusive focused commercial...

October 24, 2025 | Friday | News
Ipsen to Acquire ImCheck Therapeutics to Advance Promising AML Immunotherapy ICT01

Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high t...

October 23, 2025 | Thursday | News
Adcytherix Raises €105 Million Series A to Advance Next-Generation Antibody–Drug Conjugates with Novel Payloads

Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads Financing led b...

October 20, 2025 | Monday | News
Thermo Fisher and OpenAI Unite to Accelerate Drug Development with Frontier AI

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s p...

October 17, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close